Meeting of the Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention, 33354 [2024-09081]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Page 33354]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09081]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2024-0034]


Meeting of the Advisory Committee to the Director (ACD), Centers 
for Disease Control and Prevention

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting for the Advisory Committee to the Director, Centers 
for Disease Control and Prevention (ACD, CDC). This meeting is open to 
the public. The meeting will be webcast live via the World Wide Web.

DATES: The meeting will be held on June 6, 2024, from 10 a.m. to 3 
p.m., EDT (times subject to change).
    The public may submit written comments from April 29, 2024 through 
May 24, 2024.

ADDRESSES: No registration is required to view the meeting via the 
World Wide Web. Information for accessing the webcast will be available 
at https://www.cdc.gov/about/advisory-committee-director/.
    Written comments: You may submit comments identified by Docket No. 
CDC-2024-0034 by either of the following methods below. Do not submit 
comments for the docket by email. CDC does not accept comments for the 
docket by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Tiffany Brown, JD MPH, Centers for Disease Control 
and Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 
30329-4027. Attn: Docket number CDC-2024-0034.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov, suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov. 
Written public comments submitted up to 72 hours prior to the ACD 
meeting will be provided to ACD members before the meeting. Written 
comments received in advance of the meeting will be included in the 
official record of the meeting.

FOR FURTHER INFORMATION CONTACT: Tiffany Brown, JD MPH, Centers for 
Disease Control and Prevention, Office of the Chief of Staff, 1600 
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027, 
Telephone: (404) 498-6655; Email Address: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee to the Director, CDC, shall (1) 
make recommendations to the Director regarding ways to prioritize the 
activities of the agency in alignment with the CDC Strategic Plan 
required under section 305(c); H.R. 2617-1252; (2) advise on ways to 
achieve or improve performance metrics in relation to the CDC Strategic 
Plan, and other relevant metrics, as appropriate; (3) provide advice 
and recommendations on the development of the Strategic Plan, and any 
subsequent updates, as appropriate; (4) advise on grant, cooperative 
agreements, contracts, or other transactions, as applicable; (5) 
provide other advice to the Director, as requested, to fulfill duties 
under sections 301 and 311; and (6) appoint subcommittees. The 
committee recommends ways to prioritize CDC's activities, improve 
results, and address health disparities. It also provides guidance to 
help CDC work more effectively with its various private and public 
sector constituents to make health protection a practical reality.
    Matters to be Considered: The agenda will include an update on CDC 
priorities from the CDC Director, discussions on CDC's work to address 
equity and social determinants of health, lab readiness and response 
improvement efforts, programmatic updates, and updates from the ACD 
Data and Surveillance Workgroup and the Communications and Public 
Engagement Workgroup. Agenda items are subject to change as priorities 
dictate.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Written Public Comment: The docket will be opened to receive 
written comments on April 29, 2024 through May 24, 2024.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-09081 Filed 4-26-24; 8:45 am]
BILLING CODE 4163-18-P